Transcription Factors and Cancer: Approaches to Targeting

Area of Science:

• Molecular Biology
• Oncology
• Drug Discovery

Background:

• Cancer is characterized by uncontrolled cell proliferation, often due to dysregulated signaling pathways.
• Transcription factors are key regulators of gene expression, crucial for normal cellular functions.
• Dysregulation of transcription factors contributes significantly to tumorigenesis and oncogenic transformation.

Purpose of the Study:

• To review current strategies for targeting transcription factors in cancer therapy.
• To highlight therapeutic approaches that have progressed to clinical trials.
• To address the challenge of targeting transcription factors, often considered "undruggable" due to their lack of enzymatic activity.

Main Methods:

• Literature review of therapeutic strategies targeting transcription factors.
• Focus on approaches that have reached clinical development.
• Analysis of transcription factor-binding partner interactions for therapeutic insights.

Main Results:

• Advancements in targeting transcription factors are emerging, challenging the "undruggable" notion.
• Several therapeutic strategies targeting transcription factors have shown promise and advanced to the clinic.
• Understanding transcription factor interactions provides new avenues for drug development.

Conclusions:

• Targeting transcription factors represents a significant therapeutic opportunity in oncology.
• Despite challenges, innovative strategies are making transcription factor-targeted therapies a reality.
• Further research into transcription factor modulation holds potential for novel cancer treatments.